Search Results

You are looking at 1 - 10 of 180 items for :

  • "chemotherapy-induced" x
Clear All
Full access

George M. Rodgers III, Pamela Sue Becker, Morey Blinder, David Cella, Asher Chanan-Khan, Charles Cleeland, Peter F. Coccia, Benjamin Djulbegovic, Jeffrey A. Gilreath, Eric H. Kraut, Ursula A. Matulonis, Michael M. Millenson, Denise Reinke, Joseph Rosenthal, Rowena N. Schwartz, Gerald Soff, Richard S. Stein, Gordana Vlahovic and Alva B. Weir III

undergoing radiotherapy to the cranium and/or spine for treatment of primary tumors of the central nervous system developed grades 3 and 4 hematologic side effects. 8 NCCN Clinical Practice Guidelines in Oncology : Cancer- and Chemotherapy-Induced

Full access

John M. Salsman, Steven M. Grunberg, Jennifer L. Beaumont, Miriam Rogers, Diane Paul, Marla L. Clayman and David Cella

, vomiting during previous chemotherapy, history of pregnancy-induced nausea and vomiting, anxiety, history of limited alcohol intake, and history of motion sickness. 6 , 7 Chemotherapy-induced nausea and vomiting (CINV) are classified into acute and

Full access

Anat Gafter-Gvili, David P. Steensma and Michael Auerbach

disease. Subsequent to that presentation, 11 other prospective randomized trials ( Table 1 ), which collectively enrolled more than 1500 patients with either chemotherapy-induced (CIA) or cancer-associated anemia (CAA), yielded similar results. Adverse

Full access

Sally Yowell Barbour

agents associated with high rates of CINV Analyze the use of corticosteroids in the treatment of acute CINV Analyze the use of corticosteroids in the treatment of delayed CINV Chemotherapy-induced nausea and vomiting (CINV) is one of the most

Full access

Barbara Todaro

The management of chemotherapy-induced nausea and vomiting (CINV) has improved over the past 20 years. Before the introduction of 5-hydroxytryptamine (5-HT3) receptor antagonists, treatment options were limited to less-effective and more

Full access

Ting Bao

; 59 : 142 – 149 . 6 Pearl ML Fischer M McCauley DL . Transcutaneous electrical nerve stimulation as an adjunct for controlling chemotherapy-induced nausea and vomiting in gynecologic oncology patients . Cancer Nurs 1999 ; 22 : 307 – 311

Full access

Joseph A. Roscoe, Gary R. Morrow, Jane T. Hickok, Karen M. Mustian and Abhay R. Shelke

and Prochlorperazine in patients with chemotherapy-induced nausea and vomiting . N Engl J Med 1981 ; 305 : 905 – 909 . 3 Morrow GR Roscoe JA Hickok JT . Nausea and Vomiting . In: Holland JC. , ed. Psycho-oncology. New York : Oxford

Full access

Abiy Agiro, Andrea DeVries, Jennifer Malin and Michael J. Fisch

CSF administration decreases chemotherapy-induced FN and associated complications. 8 , 9 , 21 , 30 – 32 CSF prophylaxis is recommended for patients receiving chemotherapy regimens considered to be at high risk of causing FN, or patients receiving

Full access

Michaela A. Dinan, Bradford R. Hirsch and Gary H. Lyman

granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours . Eur J Cancer 2011 ; 47 : 8 – 32 . 24. Smith TJ Khatcheressian J

Full access

George M. Rodgers

Cancer- and Chemotherapy-Induced Anemia during its early years and have chaired it since 2004. Major changes in the NCCN Guidelines on anemia over the years have focused on 2 topics: erythropoiesis-stimulating agent (ESA) safety and the increasing use of